Precision oncology is the study of how changes in cellular genes can ultimately drive the development of cancer. Knowledge of tumor genetic makeup is increasingly recognized as a potential means to determine therapies that may be likely to work against those tumors. This precise approach to care promises a means of specifically tailoring therapy to individual patients – and provides physicians a more accurate prediction of which therapies are most likely to work.
West Cancer Center continues to pursue and initiate clinical studies specifically in precision oncology. Rather than separating clinical studies by disease type, West Cancer Center has a series of clinical trials based on a tumor’s molecular abnormalities – regardless of disease type.
This reflects a novel understanding of cancer biology in which the cancer site of origin plays less of a role, while particular abnormalities in the cancer genome serve as the primary driving force behind the development and spread of malignancy.